General MedicationsINTRAVENOUSStandard
TYZAVAN
VANCOMYCIN HYDROCHLORIDE
Standard Dose
EQ 1.75GM BASE/350ML (EQ 5MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview TYZAVAN is listed in Drugs@FDA under application 211962 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient VANCOMYCIN HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - EQ 1.75GM BASE/350ML (EQ 5MG BASE/ML) Sponsor HIKMA Submission history Latest submission status date: 2025-06-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview TYZAVAN is listed in Drugs@FDA under application 211962 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient VANCOMYCIN HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - EQ 1.75GM BASE/350ML (EQ 5MG BASE/ML) Sponsor HIKMA Submission history Latest submission status date: 2025-06-27 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.